| Literature DB >> 34734000 |
Bo Li1, Qing-Liang Chen1, Bo-Chen Yao1, Nan Jiang1, Feng Zhao1, Min Ren2, Jing Sun1, Li-Na Xu1, Zhi-Gang Guo1.
Abstract
BACKGROUND: Stanford type A aortic dissection (TAAD) has a sudden onset and high mortality, and emergency total aortic arch replacement (TAAR) is the main treatment option for TAAD. The mortality rate of patients with postoperative acute kidney injury (AKI) combined with continuous renal replacement therapy (CRRT) is remarkable higher than that of patients without AKI. However, incidence of AKI and risk factors for CRRT following TAAR isn't entirely understood.Entities:
Keywords: Acute kidney injury (AKI); continuous renal replacement therapy (CRRT); moderate hypothermia circulatory arrest (MHCA); total aortic arch replacement (TAAR); type A aortic dissection (TAAD)
Year: 2021 PMID: 34734000 PMCID: PMC8506709 DOI: 10.21037/atm-21-3905
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Preoperative variables
| Variable | Control group | CRRT group | T-value or χ2 value | P value |
|---|---|---|---|---|
| Gender (M/F, n) | 48/24 | 35/14 | 0.31 | 0.58 |
| Age (year) | 57.2±10.2 | 56.6±12.6 | –0.27 | 0.79 |
| Smoking, n (%) | 38 (52.8) | 27 (55.1) | 0.06 | 0.80 |
| Drinking, n (%) | 22 (30.6) | 12 (24.5) | 0.53 | 0.47 |
| Complications, n (%) | ||||
| Hypertension | 55 (76.4) | 39 (79.6) | 0.17 | 0.68 |
| Diabetes | 2 (2.8) | 0 (0.0) | 1.38 | 0.24 |
| Cerebrovascular accident | 4 (0.0) | 2 (2.8) | 0.13 | 0.71 |
| Coronary heart disease | 8 (16.3) | 8 (11.1) | 0.69 | 0.41 |
| Echocardiography measurements | ||||
| Aortic sinus diameter (mm) | 42.2±6.8 | 45.3±6.8 | 0.50 | 0.05 |
| Ascending aorta diameter (mm) | 47.2±7.1 | 46.9±6.6 | –0.20 | 0.84 |
| LAEDD (mm) | 36.9±4.4 | 36.1±6.1 | –0.76 | 0.45 |
| LVEDD (mm) | 52.6±6.2 | 52.4±7.8 | –0.15 | 0.88 |
| LVEF (mm) | 56.0±5.0 | 54.9±7.5 | –0.85 | 0.40 |
| Mitral valvular lesion, n (%) | 8 (11.1) | 3 (6.1) | 0.88 | 0.35 |
| Aortic valvular lesions, n (%) | 27 (37.5) | 25 (51.0) | 2.18 | 0.14 |
| Combined surgery, n (%) | ||||
| Ascending aorta replacement | 39 (54.2) | 22 (44.9) | 0.31 | 0.58 |
| AVR/AVP | 7 (9.7) | 2 (4.1) | 1.09 | 0.30 |
| Wheat | 3 (4.2) | 0 (0.0) | 2.09 | 0.15 |
| Bentall | 12 (16.7) | 18 (36.7) | 6.30 | 0.01 |
| CABG | 6 (4.2) | 3 (6.1) | 0.19 | 0.66 |
| MVR | 2 (2.8) | 0 (0.0) | 1.30 | 0.25 |
LAEDD, left atrial end-diastolic dimension; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; CRRT, continuous renal replacement therapy; AVR/AVP, aortic valve replacement/aortic valve repair; CABG, coronary artery bypass graft; MVR, mitral valve replacement; CRRT, continuous renal replacement therapy.
Operative variables
| Variable | Control group | CRRT group | T-value or χ2 value | P value |
|---|---|---|---|---|
| CPB and perfusion | ||||
| CPB time (min) | 177.0±42.4 | 191.4±53.6 | 1.64 | 0.10 |
| Aortic cross-clamp time (min) | 102.4±27.6 | 107.8±30.9 | 1.00 | 0.32 |
| Circulatory arrest time (min) | 15.1±8.7 | 13.1±11.6 | −1.04 | 0.30 |
| Cerebral perfusion time (min) | 15.1±9.0 | 14.8±15.4 | −0.14 | 0.89 |
| Circulatory arrest temperature (anal temperature °C) | 27.9±2.3 | 27.6±1.8 | −0.71 | 0.48 |
| Intraoperative blood product | ||||
| Red blood cells (U) | 1.1±2.3 | 2.4±3.4 | 2.41 | 0.02 |
| Platelets (therapeutic dose) | 1.1±0.7 | 1.7±0.8 | 3.86 | 0.00 |
| Fresh frozen plasma (mL) | 547.3±383.8 | 357.7±335.8 | −2.70 | 0.01 |
| Autologous blood (mL) | 950±399.9 | 1,322.6±810.8 | 3.33 | 0.00 |
| Drainage volume | ||||
| Intraoperative bleeding (mL) | 1,270.0±508.4 | 1,577.7±824.6 | 2.47 | 0.02 |
| Postoperative drainage (mL) | 1,036.6±801.4 | 1,185.2±923.3 | 0.91 | 0.37 |
CPB, cardiopulmonary bypass; CRRT, continuous renal replacement therapy.
Figure 1Changes in postoperative sCr levels. CRRT, continuous renal replacement therapy; sCr, serum creatinine.
Univariate analysis of variables associated with CRRT
| Risk factors | B-value | Wald χ2 value | P value | OR value | 95% CI |
|---|---|---|---|---|---|
| Aortic sinus diameter (mm) | 0.066 | 3.729 | 0.053 | 1.068 | 0.999–1.141 |
| Bentall procedure [n (%)] | 1.066 | 6.048 | 0.014 | 2.903 | 1.242–6.788 |
| Red blood cells (U) | 0.159 | 5.120 | 0.024 | 1.172 | 1.022–1.345 |
| Platelets (therapeutic dose) | 1.039 | 12.033 | 0.001 | 2.826 | 1.571–5.083 |
| Fresh frozen plasma (mL) | −0.001 | 6.685 | 0.010 | 0.999 | 0.998–1.000 |
| Autologous blood (mL) | 0.001 | 8.391 | 0.004 | 1.001 | 1.000–1.002 |
| Intraoperative bleeding (mL) | 0.001 | 5.228 | 0.022 | 1.001 | 1.000–1.001 |
| Intraoperative transfusion score | 1.239 | 22.744 | 0.000 | 3.452 | 2.075–5.744 |
CRRT, continuous renal replacement therapy; OR, odds ratio; CI, confidence interval.
Intraoperative transfusion score standard
| Assignment | Red blood cells (U) | Platelets (therapeutic dose) | Fresh frozen plasma (mL) | Autologous blood (mL) |
|---|---|---|---|---|
| 1 | >1.5 | >1.5 | ≤741.5 | >1,375 |
| 0 | ≤1.5 | ≤1.5 | >741.5 | ≤1,375 |
Multivariate analysis for CRRT [1]
| Risk factors | B value | Wald χ2 value | P value | OR value | 95% CI |
|---|---|---|---|---|---|
| Aortic sinus diameter (mm) | 0.040 | 1.139 | 0.286 | 1.041 | 0.967–1.119 |
| Bentall procedure [n (%)] | 1.335 | 5.381 | 0.020 | 3.802 | 1.230–11.750 |
| Intraoperative bleeding (mL) | 0.001 | 7.421 | 0.006 | 1.001 | 1.000–1.002 |
Hosmer-Lemeshow test χ2=5.592, P=0.693. CRRT, continuous renal replacement therapy; OR, odds ratio; CI, confidence interval.
Multivariate analysis for CRRT [2]
| Risk factors | B value | Wald χ2 value | P value | OR value | 95% CI |
|---|---|---|---|---|---|
| Aortic sinus diameter (mm) | 0.082 | 3.447 | 0.063 | 1.086 | 0.995–1.185 |
| Bentall procedure [n (%)] | 0.881 | 1.983 | 0.159 | 2.413 | 0.708–8.221 |
| Intraoperative transfusion score | 1.345 | 18.090 | 0.001 | 3.839 | 2.065–7.137 |
Hosmer-Lemeshow test χ2=12.741, P=0.121. CRRT, continuous renal replacement therapy; OR, odds ratio; CI, confidence interval.
Analysis of the predictive abilities of the 2 models
| Model indexes | ROC | P value | 95% CI |
|---|---|---|---|
| Bentall procedure and intraoperative bleeding | 0.756 | 0.000 | 0.650–0.862 |
| Aortic sinus diameter and Intraoperative transfusion score | 0.837 | 0.000 | 0.754–0.920 |
ROC, receiver operating characteristic; CI, confidence interval.
Figure 2Analysis of the ROC curves for the two models. ROC, receiver operating characteristic.